Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Fig. 1

Time Course to Headache Pain Freedom (A), Headache Pain Relief (B), and Absence of MBS (C). *P < 0.05, **P <0 .01, ***P < 0.001 vs placebo in analysis censoring for use of rescue medication. The teal/gray bars represent the percentage of patients achieving headache pain freedom (A), headache pain relief (B), and absence of MBS (C) without rescue medication use prior to the achievement. The white bars represent the percent of patients achieving headache pain freedom (A), headache pain relief (B), and absence of MBS (C) regardless of rescue medication use

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us